nitroglycerin and parthenolide

nitroglycerin has been researched along with parthenolide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolay, H; Chiarugi, A; Moskowitz, MA; Reuter, U	1
Greco, R; Morazzoni, P; Nappi, G; Riva, A; Sandrini, G; Tassorelli, C	1

Other Studies

2 other study(ies) available for nitroglycerin and parthenolide

Article	Year
Nuclear factor-kappaB as a molecular target for migraine therapy. Annals of neurology, 2002, Volume: 51, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA-Binding Proteins; Dura Mater; I-kappa B Proteins; Macrophages; Male; Migraine Disorders; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroglycerin; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sesquiterpenes; Vasodilator Agents	2002
Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine. Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Immunohistochemistry; Male; Migraine Disorders; Neurons; NF-kappa B; Nitroglycerin; Oncogene Proteins v-fos; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tanacetum parthenium; Vasodilator Agents	2005

Article

Year

Nuclear factor-kappaB as a molecular target for migraine therapy.

Annals of neurology, 2002, Volume: 51, Issue:4

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA-Binding Proteins; Dura Mater; I-kappa B Proteins; Macrophages; Male; Migraine Disorders; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroglycerin; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sesquiterpenes; Vasodilator Agents

2002

Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine.

Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:8

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Immunohistochemistry; Male; Migraine Disorders; Neurons; NF-kappa B; Nitroglycerin; Oncogene Proteins v-fos; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tanacetum parthenium; Vasodilator Agents

2005